Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
StressMood DisordersEmotional Well-being
Interventions
DIETARY_SUPPLEMENT

Melissa officinalis supplement

This intervention consists of a standardized oral dietary supplement containing 400 mg of Melissa officinalis extract formulated in phospholipids. The supplement is administered once daily for 3 weeks to evaluate its potential effects on mood, stress perception, and cortisol levels in healthy adults.

All Listed Sponsors
lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT06942897 - Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation | Biotech Hunter | Biotech Hunter